Top 10 Medical Stocks To Buy Right Now

Small cap Internet of Medical Things (IoMT) company Biotricity, Inc (OTCBB: BTCY) has just announced that it will be expanding the scope of a previously approved clinical investigation of fetal heart rate variability (fHRV) to include maternal HRV and other key physiologic metrics for maximum predictive accuracy and efficiency. This is potentially a good area to be in due to the fact that high-risk pregnancies require extensive monitoring and care during the gestational period. High-risk pregnancies are also on the rise and now account for 6 – 8% of all pregnancies in the U.S. due in part to a rise in existing maternal health conditions (such as high blood pressure and obesity) and older parental age at the time of pregnancy. This means that the maternal and fetal monitoring market is growing rapidly and is expected to be worth $2.3 Billion by 2019. 

Top 10 Medical Stocks To Buy Right Now: Pimco Corporate & Income Stategy Fund(PCN)

Advisors’ Opinion:

  • [By Shane Hupp]

    PeepCoin (PCN) uses the hashing algorithm. Its launch date was September 26th, 2016. PeepCoin’s total supply is 56,576,323,977 coins and its circulating supply is 17,376,323,977 coins. PeepCoin’s official website is dapscoin.com. The official message board for PeepCoin is medium.com/dapscoinofficial. PeepCoin’s official Twitter account is @DAPScoin and its Facebook page is accessible here. The Reddit community for PeepCoin is /r/DAPSCoin.

  • [By Max Byerly]

    PeepCoin (CURRENCY:PCN) traded down 16.9% against the U.S. dollar during the 24 hour period ending at 23:00 PM Eastern on July 9th. During the last week, PeepCoin has traded 35.9% lower against the U.S. dollar. One PeepCoin coin can currently be bought for $0.0000 or 0.00000001 BTC on popular exchanges including Cryptohub, TradeOgre, Bleutrade and C-Patex. PeepCoin has a total market cap of $619,022.00 and approximately $25,154.00 worth of PeepCoin was traded on exchanges in the last 24 hours.

  • [By Ethan Ryder]

    News stories about PIMCO Corporate & Income (NYSE:PCN) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. PIMCO Corporate & Income earned a news impact score of 0.05 on Accern’s scale. Accern also gave news articles about the investment management company an impact score of 46.3242910143552 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Joseph Griffin]

    PeepCoin (CURRENCY:PCN) traded 70.2% higher against the dollar during the 24-hour period ending at 13:00 PM ET on August 14th. During the last week, PeepCoin has traded 1.4% higher against the dollar. One PeepCoin coin can currently be bought for $0.0000 or 0.00000000 BTC on popular cryptocurrency exchanges including Trade Satoshi, CoinExchange, C-Patex and Cryptopia. PeepCoin has a total market cap of $497,805.00 and $5,648.00 worth of PeepCoin was traded on exchanges in the last 24 hours.

Top 10 Medical Stocks To Buy Right Now: Aluminum Corporation of China Ltd(ACH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Aluminum Corp. of China Limited (NYSE:ACH) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $10.70 and last traded at $10.71, with a volume of 2367 shares trading hands. The stock had previously closed at $11.00.

  • [By Max Byerly]

    Aluminum Corp. of China Limited (NYSE:ACH) has received an average rating of “Hold” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company.

  • [By Jon C. Ogg]

    Aluminum Corp. of China Ltd. (NYSE: ACH) was trading up over 7% at $11.88 in New York trading. The 52-week range is $9.20 to $23.54.

    Century Aluminum Co. (NASDAQ: CENX) was down 13.3% at $10.30, and it now has a new 52-week range of $10.13 to $24.77, with that low being put in on the same day.

  • [By Logan Wallace]

    Banco de Sabadell S.A acquired a new position in Aluminum Corp. of China Limited (NYSE:ACH) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 25,227 shares of the basic materials company’s stock, valued at approximately $340,000.

  • [By Ethan Ryder]

    Aluminum Corp. of China Limited (NYSE:ACH) has been assigned a consensus recommendation of “Hold” from the eight research firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company.

  • [By Max Byerly]

    Aluminum Corp. of China Limited (NYSE:ACH) has been assigned an average recommendation of “Hold” from the seven ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company.

Top 10 Medical Stocks To Buy Right Now: Minerva Neurosciences, Inc(NERV)

Advisors’ Opinion:

  • [By Max Byerly]

    Minerva Neurosciences (NASDAQ:NERV) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

    Nuvectra (NASDAQ:NVTR) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

  • [By Shane Hupp]

    AnaptysBio (NASDAQ: NERV) and Minerva Neurosciences (NASDAQ:NERV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

  • [By Lisa Levin] Gainers
    Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 92.1 percent to $7.01.
    iPic Entertainment Inc. (NASDAQ: IPIC) gained 21.6 percent to $9.73.
    Baozun Inc. (NASDAQ: BZUN) shares jumped 18.7 percent to $53.49 after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) shares jumped 15.9 percent to $50.50. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.
    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 14.7 percent to $ 20.46 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) climbed 13.4 percent to $5.5009.
    Endocyte, Inc. (NASDAQ: ECYT) rose 13.3 percent to $ 14.23 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting.
    Diana Containerships Inc. (NASDAQ: DCIX) gained 12.9 percent to $1.7499 after the company announced the sale of Post-Panamax Container Vessel for $21 million.
    Essendant Inc. (NASDAQ: ESND) gained 12.7 percent to $12.43. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash.
    Blink Charging Co (NASDAQ: BLNK) rose 11.8 percent to $8.04 after surging 31.68 percent on Wednesday.
    OptimumBank Holdings, Inc. (NASDAQ: OPHC) gained 11.5 percent to $5.15.
    Flotek Industries, Inc. (NYSE: FTK) shares climbed 10.7 percent to $3.74.
    Farmer Bros. Co. (NASDAQ: FARM) rose 7.9 percent to $25.95 after climbing 7.90 percent on Wednesday.
    Minerva Neurosciences Inc (NASDAQ: NERV) rose 6.5 percent to $6.93 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients.
    Williams Partners L.P. (NYSE: WPZ) rose 5.6 percent to $40

Top 10 Medical Stocks To Buy Right Now: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Helen of Troy Limited (NASDAQ:HELE) have been assigned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $115.75.

  • [By Motley Fool Staff]

    Helen of Troy Limited (NYSE: HELE)Q1 2019 Helen Of Troy Limited Earnings Conference callJul. 09, 2018, 1:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Steve Symington]

    Shares of Helen of Troy Limited (NASDAQ:HELE) climbed 12.7% on Monday after the consumer brand housewares, health, home, and beauty products company announced strong fiscal first-quarter 2019 results.

  • [By Shane Hupp]

    Helen of Troy (NASDAQ:HELE) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday.

  • [By Logan Wallace]

    Helen of Troy (NASDAQ:HELE) issued its quarterly earnings data on Tuesday. The company reported $1.98 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.59 by $0.39, Bloomberg Earnings reports. The firm had revenue of $393.50 million during the quarter, compared to analyst estimates of $349.19 million. Helen of Troy had a return on equity of 19.01% and a net margin of 4.84%. The business’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.65 earnings per share. Helen of Troy updated its FY 2019 guidance to $7.65-7.90 EPS and its FY19 guidance to $7.65-7.90 EPS.

Top 10 Medical Stocks To Buy Right Now: Ionis Pharmaceuticals, Inc.(IONS)

Advisors’ Opinion:

  • [By Cory Renauer]

    Although Spinraza’s trajectory could quickly reverse, Biogen made a smart move by expanding its investment into the company that discovered it, Ionis Pharmaceuticals (NASDAQ:IONS). Unfortunately, Ionis probably won’t be adding any candidates to Biogen’s ultra-risky late-stage pipeline right away.

  • [By Chris Lange]

    Akcea Therapeutics Inc. (NASDAQ: AKCA) shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) that they had received a marketing authorization approval from the European Commission (EC).

  • [By Cory Renauer]

    This Ionis Pharmaceuticals (NASDAQ:IONS) spinoff earned approval to market a rare disease drug called Tegsedi in the European Union earlier this year, but the U.S. Food and Drug Administration (FDA) won’t make a decision about the drug we also know as inotersen until October. In the meantime, the agency is expected to deliver an approval decision on or before August 30 for Waylivra, formerly volanesorsen, and the outcome is far from certain.

  • [By Dan Caplinger]

    Tuesday turned out to be a relatively quiet session on Wall Street, as the S&P 500 and other major benchmarks made modest gains to continue their impressive summer rally. Between favorable economic data and continued confidence in the lasting power of a bull market that’s approaching its 10th anniversary, investors seem inclined to accentuate the positive and ignore worries about future setbacks. Yet a few stocks did lose ground due to bad news affecting individual companies. Canopy Growth (NYSE:CGC), Mitek Systems (NASDAQ:MITK), and Ionis Pharmaceuticals (NASDAQ:IONS) were among the performers in the market. Here’s why they did so poorly.

Top 10 Medical Stocks To Buy Right Now: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.

Top 10 Medical Stocks To Buy Right Now: Points International, Ltd.(PCOM)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about Points International (NASDAQ:PCOM) (TSE:PTS) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Points International earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news articles about the information services provider an impact score of 48.0880042366604 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Joseph Griffin]

    Royal Bank of Canada reiterated their buy rating on shares of Points International (NASDAQ:PCOM) (TSE:PTS) in a report issued on Thursday morning. The brokerage currently has a $19.00 target price on the information services provider’s stock, up from their prior target price of $17.00.

  • [By Max Byerly]

    Points International Ltd. (NASDAQ:PCOM) (TSE:PTS) hit a new 52-week high and low on Wednesday . The stock traded as low as $15.08 and last traded at $15.00, with a volume of 402 shares traded. The stock had previously closed at $14.91.

  • [By Logan Wallace]

    Points International Ltd. (TSE:PTS) (NASDAQ:PCOM) insider Inez Mary Christine Murdoch sold 2,726 shares of the stock in a transaction dated Friday, June 29th. The stock was sold at an average price of C$21.12, for a total transaction of C$57,573.12.

Top 10 Medical Stocks To Buy Right Now: Targa Resources, Inc.(TRGP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    There’s just one problem with all that production: It needs to get out of the basin, which is a problem right now since there aren’t enough pipelines. Because of that, some of the best ways to play the Permian production boom are pipeline companies. Three perfectly positioned to profit from the Permian boom are Plains All American Pipeline (NYSE:PAA), Targa Resources (NYSE:TRGP), and Kinder Morgan (NYSE:KMI).

  • [By Matthew DiLallo]

    Meanwhile, Targa Resources (NYSE:TRGP) has been targeting investment opportunities focused on natural gas and NGLs and currently has more than $2 billion in projects under way. The company is one of the partners on Kinder Morgan’s Gulf Coast Express pipeline as well as on the proposed Whistler project that would also move gas out of the Basin. In addition to that, Targa is building the Grand Prix Pipeline, which will transport NGLs out of both the Permian and STACK shale play. These projects have the potential to nearly double Targa’s earnings by 2021.

  • [By Lee Jackson]

    This top energy MLP has had a string of positives lately. Targa Resources Corp (NYSE: TRGP) is a leading provider of midstream services and is one of the largest independent midstream energy companies in North America. Targa owns, operates, acquires and develops a diversified portfolio of complementary midstream energy assets.

  • [By Joseph Griffin]

    Shares of Targa Resources Corp (NYSE:TRGP) have been assigned a consensus rating of “Hold” from the twenty-four research firms that are covering the firm, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month target price among brokers that have covered the stock in the last year is $55.63.

  • [By Matthew DiLallo]

    Targa Resources (NYSE:TRGP) currently offers a well-above-average dividend that yields 6.6%. In exchange for that high yield, investors need to accept a higher level of risk since the company barely generates enough cash flow to cover that payout, which is one of several red flags.

Top 10 Medical Stocks To Buy Right Now: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    According to a recent report by Reuters, ConocoPhillips (NYSE:COP) has held talks with investment banks about helping the company unload its stake in Cenovus Energy (NYSE:CVE). That sale could net the oil giant more than $2 billion in cash, which would bolster its already sizable cash war chest and give it more money to allocate in creating value for investors.

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short rose slightly to 21.33 million from the previous level of 21.01 million. Shares were trading at $64.79, within a 52-week range of $42.27 to $71.71.

  • [By Joseph Griffin]

    10 15 Associates Inc. lowered its holdings in ConocoPhillips (NYSE:COP) by 1.3% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 207,906 shares of the energy producer’s stock after selling 2,741 shares during the period. ConocoPhillips makes up 2.9% of 10 15 Associates Inc.’s holdings, making the stock its 8th biggest holding. 10 15 Associates Inc.’s holdings in ConocoPhillips were worth $12,327,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Buy Right Now: National Western Life Group, Inc.(NWLI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    National Western Life Group (NASDAQ:NWLI) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday.

  • [By Logan Wallace]

    National Western Life (NASDAQ: NWLI) and Brighthouse Financial (NASDAQ:BHF) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

  • [By Stephan Byrd]

    Millennium Management LLC trimmed its holdings in shares of National Western Life Group Inc (NASDAQ:NWLI) by 64.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,115 shares of the financial services provider’s stock after selling 1,993 shares during the period. Millennium Management LLC’s holdings in National Western Life Group were worth $340,000 as of its most recent filing with the SEC.

Leave a Reply

Your email address will not be published. Required fields are marked *